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Abstract: A marine sulfate-reducing bacterium SRB-22 was isolated by means of the agar 
shake dilution method and identified as Desulfovibrio desulfuricans by morphological, 
physiological and biochemical characteristics and 16S rDNA analysis. In the bioassay, its 
extract showed broad-spectrum antimicrobial activity using the paper disc agar diffusion 
method. This isolate showed a different antimicrobial profile than either ampicillin or 
nystatin and was found to produce at least eight antimicrobial components by 
bioautography. Suitable fermentation conditions for production of the active constituents 
were determined to be 28 day cultivation at 25 °C to 30 °C with a 10% inoculation ratio. 
Under these conditions, the SRB-22 was fermented, extracted and chemically investigated. 
So far an antimicrobial compound, mono-n-butyl phthalate, and an inactive compound, 
thymine, have been isolated and characterized.  
 
Keywords:  marine sulfate-reducing bacterium; isolation; identification; broad-spectrum 
antimicrobial activity; mono-n-butyl phthalate  
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1.  Introduction 
 
Obligate anaerobic microbes mainly include photosynthetic bacteria, sulfate-reducing bacteria, 
methanogenic bacteria, denitrifying bacteria and so on. Because of their unique enzyme systems and 
metabolic pathways, these microorganisms lead quite different lives from the common aerobic 
organisms and accordingly, they should theoretically produce structurally quite different secondary 
metabolites. However, our knowledge about their bioactive compounds, their potential biomedical use 
as drug lead compounds, and their chemecological role has been truly limited. This situation may be 
due to the difficulties in the isolation and cultivation of these anaerobic microorganisms. Nevertheless, 
some recent progress in these areas inspired us to continue probing into the anaerobic microbial world 
to investigate its natural products chemistry. For example, 3,7,12-trihydroxy-24-cholanic acid 
methylester, a potent antimicrobial agent, was reported to be produced by a facultative Streptococcus 
faecium when it was cultured under strict anaerobic conditions [1]. Also reported was the   
bacteriocin-like substance(s) produced by a strict anaerobic Fusobacterium mortiferum [2].  
Sulfate-reducing bacteria are widely distributed in deep water and sediments of lakes, rivers, and 
oceans. With the capacity to use sulfate, sulfite, thiosulfate or even elemental sulfur as electron 
receptors instead of oxygen in their respiratory chain, they participate in the recycle of elemental sulfur 
in Nature. The search for bioactive compounds from this special microbial resource and their possible 
biomedical use is an interesting topic that has rarely been reported before. In our research, a marine 
sulfate-reducing bacterium SRB-22 was isolated from a sea water sample. Herein we report its 
isolation, identification, broad-spectrum antimicrobial activity, fermentation conditions, and 
preliminary chemical investigation of the compounds responsible for the observed antimicrobial 
properties. 
 
2. Results and Discussion  
 
2.1. Strain Isolation 
 
The benthal sea water sample for strain isolation was collected in the Dalian sea area, China. 
Isolation was performed by an agar-shake-dilution purification process following an enrichment 
cultivation in sulfate-containing medium [3]. An anaerobic vibrio-like bacterium was obtained. This 
isolate was able to form black colonies within the solid Fe
2+-containing medium and gave out the 
typical rotten egg odor of H2S in liquid culture, indicating that it was a sulfate-reducing bacterium. 
Accordingly it was designated as SRB-22.  
The agar shake-dilution technique is a more convenient method than the usually used Hungate 
rolling tube technique [4]. In this method, the mixture of melted paraffin wax and paraffin oil (1:3, v/v) 
was poured onto the surface of an agar tube culture to insulate the medium from oxygen. Vitamin C 
and sodium thioglycolate were added to maintain a low redox potential in the medium. Under these 
anaerobic conditions, the anaerobic bacteria grew well and formed colonies.  
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2.2. Taxonomy 
 
The isolate SRB-22 was a Gram negative bacterium. Its cells were curved, with a width of   
0.6–0.8 µm and a length of 2.0–5.0 µm, having a single polar flagellum for movement (Figure 1 A-C). 
This isolate was an obligate anaerobe. As mentioned above, it was able to produce H2S and FeS in 
media containing sulfate and Fe
2+. The desulfoviridin test gave a positive result, revealing that 
desulfoviridin, a characteristic sulfites reductase for the most species of genus Desulfovibrio, was 
present in the cells of SRB-22 [5].  
 
Figure 1. The Transmission Electronic Microscopic (A-B) and Light Microscopic (C) 
images of SRB-22. A. Showing two newly divided cells with single polar flagellum;   
B. Enlarged image of A. 
 
 
In the physiological and biochemical experiment, the SRB-22 isolate showed the ability to use 
lactate, pyruvate, malate, and choline, but not acetate or butyrate as electron donors in the presence of 
sulfate as an electron acceptor. Also it was able to grow fermentatively on malate and pyruvate when 
lacking sulfate as electron acceptor. Growth factors, i.e. yeast extract or multiple vitamins, were not 
necessary for its growth.  
The above morphological, physiological and biochemical characteristics showed that the isolate 
SRB-22 was very similar to the D. desulfuricans sp. recorded in Bergery’s Manual of Systematic 
Bacteriology [5]. The PCR amplification of 16S rDNA from isolate SRB-22 gave a sequence of   
1,467 bp in length, which was submitted and deposited in GenBank with the accession number of 
FJ873799. Based on a BLASTn search of GenBank, the closest matches to isolate SRB-22 were 
Desulfovibrio desulfuricans subsp. desulfuricans AF192153 (nucleotide identity: 100%), D. 
desulfuricans  M34113 (nucleotide identity: 100%) and D. desulfuricans DQ092636 (nucleotide 
identity: 99%). On the basis of the above morphological, physiological and biochemical 
characteristics, and 16S rDNA analysis, the isolate SRB-22 was finally identified as Desulfovibrio 
desulfuricans.  
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2.3. Antimicrobial Activity 
 
In an antimicrobial test using the paper disk diffusion method, the organic extract of the isolate 
SRB-22’s ferment broth was screened on its activity against five test bacteria and three test fungi 
(yeasts). An autoclaved blank medium extract was used as a blank control. The dose of concentrated 
extract on each paper disc was equal to the amount of substances extractable from 10 mL of ferment 
broth. 
The results are shown in Figure 2A. After adjustment for the effect of blank medium, the SRB-22 
extract showed solid inhibitory activity against both of the G
+ bacteria (Staphylococcus epidermidis 
and  Bacillus subtilis), all the three G
- bacteria (Pseudomonas fluorescens,  P. aeruginosa and 
Escherichia coli), and two of the three fungi (Cryptococcus neoformans and Candida albicans). It was 
noticed that the blank control also showed moderate activity against five bacteria and one fungus, 
which could have been caused by residual vitamin C still present after autoclaving. As is known, 
vitamin C is reported to possess antimicrobial activities [6–7]; however, it can be largely destroyed by 
Fe
2+ in the medium and the high temperatures during the autoclaving process [8–9].  
Since the antimicrobial spectrum of the SRB-22 extract was different from that of the ampicillin 
and nystatin positive controls (Figure 2B and 2C), this isolate was presumed to be able to produce 
antimicrobial agents with different mechanisms of action than the positive controls. 
 
Figure 2. The antimicrobial activities of the organic extract of SRB-22 isolate, blank 
control, ampicillin at 6 μg/mL, and
  nystatin at 100 μg/mL. Abbreviations:   
SE = Staphylococcus epidermidis, BS = Bacillus subtilis, PF = Pseudomonas fluorescens, 
PA = P. aeruginosa, EC = Escherichia coli, CN = Cryptococcus neoformans,  
CA = Candida albicans, RR = Rhodotorula rubra. The respective light color columns in A 
show the activities of blank control, i.e., the extract of blank medium. 
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To reveal the antimicrobial constituents clearly by bioautography, 20 mg of SRB-22 extract was 
partitioned into five fractions (fractions 1–5) by preparative thin layer chromatography (pTLC). The 
anti-Bacillus subtilis bioautography of these fractions clearly showed that there were at least five 
antibacterial components A-E with quite different Rf values (Figure 3-1).  
 
Figure 3. The antimicrobial bioautographies of fractions of SRB-22 extract against 
Bacillus subtilis (1) and Candida albicans (2). 
 
 
The remarkable differences in their polarity suggested different structure types, so it is possible that 
the SRB-22 isolate could produce various different types of antibiotics. As to their mechanisms of 
action, they could be either different types of antibiotics with broad-spectrum activity towards G
+ and 
G
- bacteria, or ones with specific killing mechanisms towards different types of bacteria. Likewise, the 
anti-C. albicans bioautography of the fractions also showed the presence of at least three active 
components A´–C´ with remarkably different polarities (Figure 3-2). The structures and pharmacology 
of the active compounds is under investigation and will be reported in due course.  
Furthermore, according to their distribution in the fractions and Rf values, most of the antibacterial 
components should be different from the antifungal ones. For example, spots A, D and E in fraction 1 
showed anti-B. subtilis activity while no anti-C. albicans activity, as did spot B in fraction 3 and C in 
fraction 5. Likewise, antifungal spot A´ in fraction 2 and spot C´ in fraction 3 didn’t show remarkable 
antibacterial activity.  
As is known, vitamin C has antimicrobial activity and strong polarity. When analyzed together with 
the SRB-22 extract under the same TLC condition (CH2Cl2/MeOH/triethylamine, v/v/v, 10:1:0.02), 
pure vitamin C showed a very low Rf value of about 0–0.15. After autoclaving and possible 
metabolism, part of the vitamin C could possibly still remain in the culture medium and thus be mixed 
into the final organic extract. Fraction 5 was the most polar one obtained from the extract, so the 
residue of vitamin C was probably contained therein. Nevertheless, this fraction was eluted from the 
silica from the most polar band on the pTLC plate by a medium polarity solvent mixture, 
CH2Cl2/MeOH (v/v, 1:1), and was also finally dissolved in this solvent, so accordingly, the content of 
vitamin C in this sample should be limited. In view of similar polarities, the weak inhibitory spot with 
the Rf value 0.1–0.2 in fraction 5 was speculated to be due to the residue of vitamin C. Similarly, the 
other remaining strong polar organic salts contained in medium, including sodium thioglycolate and 
sodium lactate, should also be not the main active components in the bioautographies. Mar. Drugs 2009, 7                                                  
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2.4. Study on Fermentation Conditions 
 
For further chemical investigation of the antimicrobial compounds, enough active crude extract was 
necessary. To obtain high yield of the active constituents, different temperatures, culture cycles and 
inoculation amounts were taken to optimize the fermentation conditions. In these experiments, the 
activity against the bacterium Bacillus subtilis and the yeast Candida albicans were used to evaluate 
the effects of the optimization. 
Temperature and culture cycle are usual key factors of any fermentation. As shown in Figure 4A, 
the strongest antimicrobial activity was produced when cultivated at 25 °C to 30 °C, and when 
cultivated at 25 °C, the yield of antimicrobial substances reached its peak value after 4 weeks’ 
fermentation (Figure 4B). 
 
Figure 4. The bioactivity of samples under different culture temperatures (A), under 
different culture cycles (B), and under different inoculation amounts (C). “■” presented the 
activity against B. subtilis; “∆” presented the activity against C. albicans. 
 
 
Inoculum amount was also an important factor. As shown in Figure 4C, when cultivated at 25 °C 
for four weeks, the culture with 10% inoculation ratio exhibited the strongest inhibition against the two 
test microorganisms. Inoculation ratios higher than 10% seemed to reduce the bioactive substances’ 
yield, which was probably due to the exhaustion of nutrition due to the excessively fast growth. On the 
basis of the above single-factor experiment, a suitable fermentation condition was primarily 
determined as 4 weeks’ fermentation at 25 °C to 30 °C with an inoculation ratio of 10% (v/v), which 
was also coincidently close to the fermentation conditions previously used for the antimicrobial assays. 
As shown in Figure 3, under these conditions (30 days, 10% inoculation ratio, 28 °C) the diameters of 
inhibition zones against B. subtilis and C. albicans attained 16.0 ± 0.5 mm and 14.1 ± 0.3 mm, 
respectively, which were remarkably higher than the peak values in the single-factor experiment.  
 
2.5. Preliminary Purification and Characterization of Antimicrobial Compounds 
 
After a large scale (150 L) anaerobic fermentation under the optimized conditions, an antimicrobial 
compound 1 (Figure 5) was obtained as a colorless powder by bioguided isolation. The analysis of the 
1H- and 
13C-NMR spectra showed that 1 was mono-n-butyl phthalate by comparison of its spectral data 
with data in references [10–11]. Compound 1 showed broad spectrum antimicrobial activities in the Mar. Drugs 2009, 7                                                  
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assay. The diameters of the inhibition zones against Candida albicans, Staphylococcus epidermidis, 
Escherichia coli,  Pseudomonas fluorescens, and P. aeruginosa were 7, 7, 7, 6.5, and 7 mm, 
respectively, at a dose of 50 μg per disc. According to these relatively moderate or weak inhibition 
zones, compound 1 should be a minor antimicrobial product of SRB-22. 
 
Figure 5. Compounds 1 and 2. 
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A literature survey indicated that a similar compound, dibutyl phthalate (DBP) has often been 
isolated from marine plants and microorganisms and there is considerable debate about its origins as a 
natural product or an environmental pollutant [12–15]. For example, Namikoshi et al. reported that 
DBP from three seaweeds had much higher 
14C content than the industrial DBP derived from the fossil 
fuel, i.e., petroleum, which supported a biological origin of the DBP [12]. By a 
14C-enriched NaHCO3 
feeding experiment, Chen et al. also found that a red alga was able to produce natural DBP. Although 
mono-n-butyl phthalate (MBP) hasn’t been previously reported from marine environment, these data 
suggest with high probability a possible biological origin for 1.  
 
Figure 6. HPLC analysis of compound 1, crude extract of SRB-22 and analytically pure 
methanol under the same chromatographic condition. 
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Additionally, the SRB-22 crude extract for antimicrobial assay was fermented in clean glass serum 
bottles and dissolved in analytically pure methanol after rotary evaporation. The analytically pure 
methanol was shown to be DBP and MBP free as tested by high performance liquid chromatography 
(HPLC), so we conclude that any possible contamination by DBP was avoided. The HPLC analysis of 
this crude extract also showed the presence of the MBF peak (retention time: 2.34 min; maximum UV 
absorption at 222 nm and 278 nm) (Figure 6), which further supported the biological origin of 1. 
Considering its structure, it may be a biodegraded product of the natural or artificial DBP. As for its 
exact origin and biosynthesis pathway, further research on 
14C content measurement or 
14C-enriched 
carbon source feeding experiments are needed. 
Besides compound 1, an inactive known compound, thymine (2, Figure 5) [16], was isolated and 
characterized from the n-butanol extract of another batch of SRB-22 ferment broth. Its spectral data are 
not shown. 
The other active fractions are still under purification. In the isolation of this anaerobic bacterium’s 
metabolites, some difficulties have been encountered. For example, some compounds usually showed 
high similar polarities, insensitivity to chemical chromogenic reagents, or weak UV absorptions, which 
made the purification inconvenient. However, more efforts and techniques will be put into the isolation 
of the antimicrobial compounds and further progress is expected.  
 
3. Conclusions 
 
By use of convenient agar shake dilution method, a sulfate reducing bacterium SRB-22 was 
obtained. This isolate was identified as Desulfovibrio desulfuricans on the basis of morphology, 
physiological and biochemical characteristics, and 16S rDNA analysis. In the antimicrobial assay, the 
extract of isolate SRB-22 showed broad-spectrum activity against two kinds of G
+ bacteria, three kinds 
of G
- bacteria, and two kinds of fungi. Its mechanism of action is presumed to be different from those 
of the positive control ampicillin and nystatin. The anti-Bacillus subtilis and anti-Candida albicans 
bioautographies showed that at least five antibacterial and three antifungal components were produced 
by the isolate.  
Suitable fermentation conditions for the production of anti-Bacillus subtilis and anti-Candida 
albicans compounds was primarily determined to be the cultivation at 25 °C to 30 °C for 4 weeks with 
10% inoculation ratio. Under these conditions, the SRB-22 was fermented on a large-scale, extracted 
and chemically investigated for its antimicrobial compounds. So far, a first active compound, n-butyl 
phthalate (1) was obtained and identified and it showed the moderate activity against C. albicans, S. 
epidermidis, E. coli, P. fluorescens, and P. aeruginosa. 
Sulfate-reducing bacteria, as a big family of chemically underexplored anaerobic microorganisms, 
are rarely reported as sources of new bioactive secondary metabolites and are expected to be a new 
resource for novel lead compounds because of their special metabolic pathways [17]. For its broad-
spectrum antimicrobial activity, different action modes from ampicillin and nystatin, and potential of 
producing sorts of active compounds, the isolate SRB-22 is expected to be a fertile producer of novel 
antibiotics different from the products of the aerobic biosphere. Further research on SRB-22’s 
bioactive products is ongoing and the results will be reported in due course. 
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4. Experimental 
 
4.1. Strain Isolation 
 
The benthal sea water sample was collected using a Nansen bottle in the Heshijiao sea area   
(121° 30′ 33.95″ E, 38° 48′ 41.78″ N) of Dalian, China, at a depth of about 10 m. The following 
isolation steps were performed on a common air clean bench: firstly, 50 mL of the sea water sample 
was inoculated into 450 mL sterile enrichment medium contained in a 500 mL sealed bottle, filled up 
to the lip. Then the bottle was incubated for enrichment at 30 °C for two weeks. The enrichment 
medium contained 0.5 g KH2PO4, 1.0 g NH4Cl, 1.0 g Na2SO4, 2.0 g MgSO4·7H2O, 5.0 g 70% sodium 
lactate, 1.0 g yeast extract, 0.1 g CaCl2·2H2O, 0.5 g FeSO4·7H2O, 0.1 g sodium thioglycolate and 0.1 g 
vitamin C in per 1000 mL filtrated sea water and the pH value was adjusted to 7.2–7.4 before 
autoclaving. 
One mL of enriched sample was added to a flask containing 99 mL of sterile sea water and glass 
beads, and drastically shaken to be a 10
-2 dilution This 10
-2 dilution was then further diluted 
sequentially to give 10
-3, 10
-4, 10
-5, 10
-6, 10
-7, and 10
-8 dilutions in test tubes. A 0.5 mL aliquot of each 
serial diluton (10
-4, 10
-5, 10
-6, 10
-7, and 10
-8) was transferred into a test tube and 10 mL of melted 
enrichment medium containing 1.5% agar at 50 °C was added [3]. After solidification the tube was 
sealed with a sterilized overlay consisting of paraffin wax and paraffin oil (v/v, 1/3). The overlay 
should be over 2 cm thick. Subsequently, the tubes were incubated at 30 °C in an incubator for about  
1 week. When black colonies formed in the tube, one selected colony was cut out from the broken agar 
tube, transferred into a serum bottle full of culture medium, and incubated at 30 °C for about one week. 
Then, 1 mL of this liquid culture was used for further purification and the above steps were repeated 
until pure colonies were obtained. The purity was checked by light microscope. 
 
4.2. Taxonomy 
 
Routine Gram staining reaction was performed according to the standard method [18]. The cellular 
size, shape and flagella were observed after phosphotungstic acid negative staining by a transmission 
electronic microscope (TEM). A desulfoviridin test for the identification of the genus Desulfovibrio 
was performed using the method in the reference [5]. Briefly, 30–40 mL of fresh bacterial suspension 
was filtered through a 0.45 μm filter membrane, then a drop of 2 mol/L NaOH was added to the 
membrane and fluorescence under a 365 nm ultraviolet lamp was observed. Red fluorescence was 
recorded as a positive reaction. 
In the carbon source utilization (i.e., electron donor) and growth factor requirement experiments, the 
carbon source sodium lactate and the growth factor yeast extract in the enrichment medium were 
removed from the former composition; instead, 0.032 mol/L of different organic carbon sources were 
added, including sodium lactate, sodium pyruvate, sodium malate, sodium acetate, sodium butyrate, 
and choline [5]. In some further experiments to study its dependency on sulfate as electron receptor in 
carbon source utilization, i.e., its ability of fermentative growth, all sulfates in the enrichment medium 
were also substituted by the corresponding chlorides in addition to the above modification. The above 
physiological and biochemical experiments were carried out by the following method: the   Mar. Drugs 2009, 7                                                  
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SRB-22 isolate was firstly inoculated into a new serum bottle full of the above corresponding medium 
with an inoculation ratio of 0.2% (v/v) and cultivated for one week at 30 °C. Then this new culture was 
used to seed the next generation and this subculture operation was repeated twice. The culture result in 
the basic medium was taken as negative control. Finally, the growth in the specific medium was 
recorded and used to evaluate the utilization capability to different carbon sources. 
The cells in logarithmic phase were collected by centrifugation and the total genomic DNA was 
extracted by a standard sodium dodecyl sulfate-proteinase K lysis procedure [19]. The 16S rRNA gene 
was amplified from the genomic DNA by PCR with the universal primers 27F (5′-AGAGTTTGATCC 
TGGCTCAG-3′) and 1492R(5′-TACCTTGTTACGACTT-3′) [20]. The PCR products were separated 
on 0.8% agarose gels. The DNA bands were excised from the gel and purified by using a Qiagen QIA 
quick gel extraction kit following the manufacturer’s recommended protocol. Both strands of the 
purified DNA were then sequenced by an automatic DNA sequencer (ABI) with the primers in 
Takara’s 16S rDNA Bacterial Identification PCR Kit, including RV-M (5′-GAGCGGATAACAATTT 
CACACAGG-3′), M13-47 (5′-CGCCAGGGTTTTCCCAGTCACGAC-3′), and the seq internal   
(5′-CAGCAGCCGCGGTAATAC-3′). All sequencing reactions were carried out with an ABI 3700 
automated DNA sequencer at the TAKARA Biotechnology (Dalian) Co., Ltd. Finally, the sequence 
was submitted to GenBank for deposit and BLASTn search.  
 
4.3. Sample Preparation for Antimicrobial Assay  
 
Pure bacterial suspension of SRB-22 isolate in logarithmic-phase was used to seed other serum 
bottles full of enrichment medium for bioassay, with an inoculation ratio of 10% (v/v). After   
30 days’ cultivation at 28 °C, 300 mL of the ferment broth was concentrated to dryness in vacuo by a 
rotary evaporator at 45 °C. Then the residue was dissolved in 3 mL of pure methanol and centrifuged 
at 3,000 rpm for 20 min. The supernatant was used for antimicrobial tests.  
 
4.4. Antimicrobial Assay 
 
The antimicrobial tests were performed using the KB paper disk agar diffusion method [21]. The 
Gram positive bacteria Staphylococcus epidermidis ATCC 12228 and Bacillus subtilis ATCC 6633, 
the Gram negative bacteria Pseudomonas fluorescens ATCC 13525, P. aeruginosa ATCC 9027, and 
Escherichia coli ATCC 11229, and the fungi Cryptococcus neoformans ATCC 90112, Candida 
albicans ATCC 10231 and Rhodotorula rubra DSM 10403 were used as target microorganisms. After 
incubation for 24–48 h at 37 °C, the test organisms’ lawns were washed with 0.85% NaCl sterile 
solution and diluted to 0.5 MacFarland unit (MCF) to be used as standard inoculum suspension. The 
specific media for test bacteria or fungi were poured into petri dishes and inoculated with 100 μL of 
the fresh suspension on the surface. Mueller Hinton Agar medium was used for cultivation of the test 
bacteria, and the Sabouraud Dextrose Agar medium was used for cultivation of test fungi. Each paper 
disk (φ 6 mm) was added with 100 μL of sample dissolved in methanol and then air dried for use. The 
extract of the unseeded sterilized enrichment medium was taken as blank control; ampicillin at   
6 μg/mL, and
 nystatin at 100 μg/mL were taken as positive controls; methanol was used as negative Mar. Drugs 2009, 7                                                  
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control. Finally, the Petri dishes containing the paper disks were incubated for 24 h at 37 °C before the 
measurement of inhibition zones’ diameters. Each test was performed in triplicate. 
 
4.5. Preparative TLC and Bioautography 
 
Firstly, 20 mg of the SRB-22 extract, prepared by the same method described in 4.3, was applied 
onto a 20 × 20 cm
2 thin layer chromatography (TLC) plate coated with GF254 silica gel (Qingdao 
Haiyang Chemical Company, Qingdao, China), developed with a mixture of   
CH2Cl2/MeOH/ triethylamine (v/v/v, 10:1:0.02), and air dried. According to the bands under natural 
daylight and a 254 nm ultraviolet lamp, five fractions 1–5 with increasing polarities were scraped off 
the TLC plate together with the silica gel powder. Then each fractional samples was ground, eluted 
from the silica gel with CH2Cl2/MeOH (v/v, 1:1), concentrated to dryness by rotary evaporator in 
vacuo and finally dissolved in 1 mL of CH2Cl2/MeOH (v/v, 1:1). 
Then 5 μL of each sample was applied on analytical TLC plates (Qingdao Haiyang Chemical 
Company, GF254 silica gel) with a capillary. The TLC plates were also developed by the same   
three-phase solvent system and air dried. After 20 min’s sterilization by UV light in air clean bench, 
the TLC plates were placed upward onto the surface of agar medium in Petri dishes, then 20 mL of 
melted specific medium at 45 °C (Mueller Hinton Agar for B. subtilis and Sabouraud Dextrose Agar 
for C. albicans) containing about 10
6 CFU/mL of test microorganisms were poured onto the surface of 
the TLC plates [22]. The Petri dishes were incubated at 37 °C for 16 h for B. subtilis and 24 h for C. 
albicans. Then the dishes were stained with methylthiazolyldiphenyl-tetrazolium bromide (MTT)   
(5 mg/mL) solution for clear observation and photography of inhibition spots. 
 
4.6. Study on Fermentation Conditions 
 
To improve the overall yield of the active constituents, temperature, culture cycle and inoculation 
amount were seperately investigated for their influence on the production of antimicrobial substances.  
In the temperature experiment, serum bottles, each filled with 125 mL of enrichment medium, were 
inoculated with the 10% volume of logarithmic-phase culture and incubated for 4 weeks at 4, 20, 25, 
30, 35 and 45 °C, respectively. For each temperature, three replicates were performed. Then the 
cultures were evaporated to dryness in vacuo, dissolved in 1.25 mL methanol and centrifuged to obtain 
the supernatant for antimicrobial test as described above. 
In the culture cycle experiment, the arrangement was similar. The inoculum ratio was 10% (v/v) and 
the temperature was 25 °C for all. Only the culture cycle was different, i.e., 1, 2, 3, 4, 5, 6 and 7 weeks, 
respectively. 
Likewise, in the inoculation amount experiment, the temperature was 25 °C and the culture cycle 
was four weeks for all. The difference lay in the inoculation ratios, i.e., 1%, 2.5%, 5%, 7.5%, 10%, 
15% and 20% (v/v), respectively.  
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4.7. Large-Scale Fermentation 
 
Three sterilized 50 L plastic barrels containing sterilized enrichment medium were seeded with  
7-day old bacterial suspension with an inoculation ratio of 10%. Then the barrels were filled up with 
culture medium, sealed with airtight caps, and cultivated at room temperature 25~30 °C, for 28 days.  
 
4.8. Purification and Characterization of Antimicrobial Compound 1 
 
The 150 L culture broth was sand filtered to remove FeS precipitate, absorbed by 5 kg of NKA 
macroporous absorbent resin (The Chemical Plant of Nankai University, Tianjin, China) on a column 
and consecutively eluted with deionized water and 95% aqueous ethanol. The eluent of the aqueous 
ethanol was evaporated under reducing pressure, resulting in a residue of 12 g. This extract was 
subjected to column chromotagraphy (CC) on silica gel (Qingdao Haiyang Chemical Company; 
200~300 mesh) eluting stepwise with solvents of increasing polatity from petroleum ether, CH2Cl2, to 
MeOH. The CH2Cl2/MeOH (10:1) fraction (3.1 g) was subsequently subjected to pTLC (GF254 silica 
gel) developed with CH2Cl2/MeOH/triethylamine (v/v/v, 10:1:0.02). The eluent (522 mg) from the 
band with the Rf value of 0.2–03 was then separated by CC (RP-18, Merck; MeOH/H2O 75:25 to 
100% MeOH) and semipreparative HPLC (RP-18, Hypersil, 5 μm, 8.0 × 250 mm; MeOH/H2O 85:15, 
0.02% triethylamine added; Elite P230 HPLC apparatus, Dalian, China), to yield compound 1 (5.0 mg). 
The above purification was bioguided using C. albicans and B. subtilis as indicators. The antimicrobial 
activities of compound 1 were assayed following the method described in part 4.4, above.  
Besides, an inactive compound 2 (4.0 mg) was isolated from the n-butanol extract of a previous 
batch of SRB-22’s ferment broth (60 L), by successive use of CC on silica gel (200~300 mesh), CC on 
RP-18, and semipreparative HPLC. 
The NMR spectra were recorded on a Bruker Avance 500 (500 MHz for 
1H and 125 MHz for 
13C) 
spectrometer using tetramethylsilane (TMS) as internal standard and chemical shifts were recorded as 
δ values. 
1H NMR (CDCl3) δH: 7.91 (1H, ddd, J = 7.1, 1.8, 0.8 Hz, H-3), 7.72 (1H, ddd, J = 7.1, 1.8, 
0.8 Hz, H-6),7.62–7.55 (2H, m, H-4, 5), 4.34 (2H, t, J = 6.7 Hz, H-1′), 1.73 (2H, m, H-2′), 1.45 (2H, 
m, H-3′), 0.95 (3H, t, J = 7.4 Hz, H-4′); 
13C-NMR (CDCl3) δC: 171.0 (C-1, C=O), 168.3 (C-8, C=O), 
130.5 (C-2, C), 130.0 (C-3, CH), 131.0 (C-4, CH), 132.0 (C-5, CH), 129.0 (C-6, CH), 133.2 (C-7, C), 
66.0 (C-1′, CH2), 30.5 (C-2′, CH2), 19.2 (C-3′, CH2), 13.7 (C-4′, CH3). 
The HPLC analysis of compound 1 (2.0 mg/mL), crude SRB-22 extract (the same extract used for 
antimicrobial assays), and analytically pure methanol used for dissolving samples (Kermel Chemical 
Reagent Company, Tianjin, China) was performed on the HPLC apparatus using an analytical RP-18 
column (Hypersil, 5 μm, 4.6 × 250 mm; 0~10 min, MeOH/H2O 70:30; 10~11 min, MeOH/H2O 
70:30~100:0; 11~30min, MeOH). Three μL of each sample was used for analysis. 
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